ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)
CUSIP: 04962H506
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 129,337,627
- Total 13F shares
- 311,346
- Share change
- +56,853
- Total reported value
- $1,182,680
- Put/Call ratio
- 54%
- Price per share
- $3.79
- Number of holders
- 9
- Value change
- +$252,483
- Number of buys
- 4
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 04962H506?
CUSIP 04962H506 identifies ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04962H506:
Top shareholders of ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.09%
|
120,689
|
$161,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
89,903
|
$119,000 | — | 31 Mar 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
14,000
|
$18,620 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
12,529
|
$17,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
1,550
|
$2,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
615
|
$1,000 | — | 31 Mar 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2020
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.